FDA
label_change
· 2011-12-08
FDA Approved: NASCOBAL — Supplemental Application (ENDO USA, Inc.)
Summary
FDA approved a supplemental application for NASCOBAL (cyanocobalamin) from ENDO USA, Inc., updating the product labeling for vitamin B12 deficiency-related use.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NASCOBAL (CYANOCOBALAMIN)